男女羞羞视频在线观看,国产精品黄色免费,麻豆91在线视频,美女被羞羞免费软件下载,国产的一级片,亚洲熟色妇,天天操夜夜摸,一区二区三区在线电影
Chinadaily.com.cn
 
Go Adv Search

China's mums key to Nestle baby milk deal

Updated: 2012-04-25 11:19

(Agencies)

  Comments() Print Mail Large Medium  Small

LONDON/BEIJING - The rise of the middle-class Chinese working mothers helps explain why Nestle paid nearly $12 billion for Pfizer's baby food business and could leave rivals scrambling to catch up.

Across emerging markets, nowhere more than in China, women are increasingly keeping jobs after having children -- a big driving force behind 10 percent annual growth in the $30 billion a year baby food industry.

Foreign labels such as SMA, Promil and S-26 Gold, which Nestle will get with the Pfizer deal, have a definite edge. Nestle's products include Nan, Gerber, Lactogen and Nestogen, but are less well known in China.

Baby milk was the foundation of the world's biggest food company, established in 1866 when German pharmacist Henri Nestle introduced a substitute for mothers who could not breast-feed.

Paying more for the Pfizer unit than the $10 billion that analysts had expected, Nestle trumped a bid from Danone and Mead Johnson.

The Pfizer nutrition business has 85 percent of its sales in emerging markets, and a quarter of sales in China.

Fuelled by 16 million new births a year, annual growth rates for China's baby formula market have been as high as 20 percent over the last five years. The market is forecast to double to $16 billion by 2016.

"The key strategic attraction of the deal in our view is Pfizer's No 5 position in the Chinese infant formula market where despite being global No 1 player in infant formula, Nestle has a relatively weak presence," said analyst Robert Dickinson at brokers Citi.

The Swiss giant is already market leader in milk formula in Latin America, Africa and the Middle East. This brings it the No 1 spot in Asia with its presence outside China counted too.

Globally, Nestle's baby food market share will rise to 25 percent from 19 percent - although this is likely to fall slightly after sell-offs to ensure regulatory clearance. Mead has 16 percent, Danone 14 percent and Abbott Laboratories 12 percent.

Few options for competitors

The Nestle-Pfizer business in China would only have a combined 12 percent market share behind Mead's leading 16 percent and Danone on 14 percent, but that would still be a rise from 10th place and there may be room for expansion.

Analysts looking at China expect the number of middle class households to double to 100 million by 2015.

主站蜘蛛池模板: 商城县| 弥渡县| 乌什县| 大名县| 黄冈市| 武宁县| 清丰县| 漳浦县| 湟中县| 德化县| 平遥县| 阆中市| 大兴区| 偃师市| 冕宁县| 叶城县| 通河县| 玉龙| 乌海市| 秀山| 安达市| 湟中县| 辉县市| 青田县| 合江县| 扎鲁特旗| 綦江县| 新昌县| 延吉市| 井陉县| 临夏县| 潼关县| 昭苏县| 田阳县| 六盘水市| 寿宁县| 宁波市| 永清县| 佛冈县| 鸡西市| 彰武县| 麟游县| 保德县| 望城县| 石台县| 射阳县| 睢宁县| 来安县| 兴山县| 德安县| 洪湖市| 澳门| 洮南市| 吴忠市| 理塘县| 清远市| 麻阳| 安吉县| 原阳县| 乳源| 子洲县| 临汾市| 禄丰县| 克拉玛依市| 通许县| 青川县| 汕头市| 长宁县| 肃北| 石屏县| 长汀县| 通山县| 榆中县| 利辛县| 江永县| 二连浩特市| 陵川县| 阿拉善盟| 荣成市| 清徐县| 莫力| 定边县|